Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

Edward M Kerwin,1 Thomas M Siler,2 Samir Arora,3 Patrick Darken,4 Earl St Rose,4 Colin Reisner4,5 1Clinical Research Institute of Southern Oregon, Medford, OR, USA; 2Midwest Chest Consultants, St Charles, MO, USA; 3Aventiv Research, Columbus, OH, USA; 4Pearl – a member of the AstraZeneca...

Full description

Bibliographic Details
Main Authors: Kerwin EM, Siler TM, Arora S, Darken P, St Rose E, Reisner C
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:International Journal of COPD
Subjects:
BFF MDI
chronic obstructive pulmonary disease
fixed-dose combination
inhaled corticosteroid
long-acting β2-agonist
single-inhaler triple therapy
Online Access:https://www.dovepress.com/efficacy-safety-and-pharmacokinetics-of-budesonideformoterol-fumarate--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/efficacy-safety-and-pharmacokinetics-of-budesonideformoterol-fumarate--peer-reviewed-article-COPD

Similar Items